FOSTER CITY, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage ...

VK2735 is Viking's GLP-1 agonist, and it has achieved strong results in clinical trials. Participants in a phase 2 trial who ...

From amphetamines to slimming pills, there is a long history of weight-loss drug crazes that ended in disappointment, or ...

The following is a summary of “Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real ...

Kiran Mazumdar-Shaw of Biocon aims to consolidate, accelerate biosimilar business, and reduce debt after Viatris acquisition ...

Bolt Biotherapeutics shares fell 37% after shelving its lead candidate, pivoting its pipeline, halving its staff, and upending its C-suite.

RVL Pharmaceuticals announced today that its prescription eye drop, Upneeq® (oxymetazoline hydrochloride ophthalmic solution) ...

ImmunityBio, Inc. (NASDAQ: IBRX) today announced the publication of three podcasts with UroToday highlighting the company’s ...

The US Senator took another swipe at the US prices of Novo Nordisk’s blockbuster GLP-1 receptor agonist drugs Ozempic and ...

Quest Diagnostics reported that workforce drug test cheating surged in 2023. In a phase Ib trial, a once-weekly injection of ...